Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

How bad is this news for Novavax? Let's find out. Image source: Getty Images.

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

In the latest market close, Novavax (NVAX) reached $10.35, with a +1.97% movement compared to the previous day. The stock ...

Novavax announced Wednesday that the Food and Drug Administration (FDA) has placed a clinical hold on its application for a ...

The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

Novavax’s decision has left managers of the Biologics Manufacturing Centre, which was built with nearly $130-million in federal funds, working to drum up other business for the 55,000-square-foot ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica is a writer on the Wellness team with a focus on health ...

More than three years later, that partner, Novavax Inc., won’t be making vaccines at the publicly owned plant in Montreal for the 2024-2025 season, which is part of the reason the federal ...

The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to better target the current circulating variants in the community.